These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9892040)

  • 21. The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription.
    Masuyama H; Jefcoat SC; MacDonald PN
    Mol Endocrinol; 1997 Feb; 11(2):218-28. PubMed ID: 9013769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
    Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
    Wietzke JA; Ward EC; Schneider J; Welsh J
    Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanism of the vitamin D antagonistic actions of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone depends on the primary structure of the carboxyl-terminal region of the vitamin d receptor.
    Ochiai E; Miura D; Eguchi H; Ohara S; Takenouchi K; Azuma Y; Kamimura T; Norman AW; Ishizuka S
    Mol Endocrinol; 2005 May; 19(5):1147-57. PubMed ID: 15650022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive regulation of the vitamin D receptor by its cognate ligand in heterologous expression systems.
    Santiso-Mere D; Sone T; Hilliard GM; Pike JW; McDonnell DP
    Mol Endocrinol; 1993 Jul; 7(7):833-9. PubMed ID: 8413308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characterization of ligand-dependent transactivation regions of the human vitamin D receptor].
    Nakajima S
    Nihon Rinsho; 1998 Jul; 56(7):1717-21. PubMed ID: 9702043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered gene expression profile in the kidney of vitamin D receptor knockout mice.
    Li X; Zheng W; Li YC
    J Cell Biochem; 2003 Jul; 89(4):709-19. PubMed ID: 12858337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D
    J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D resistance.
    Bouillon R; Verstuyf A; Mathieu C; Van Cromphaut S; Masuyama R; Dehaes P; Carmeliet G
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):627-45. PubMed ID: 17161336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
    Choi M; Makishima M
    Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
    Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function relationship of human parathyroid hormone in the regulation of vitamin D receptor expression in osteoblast-like cells (ROS 17/2.8).
    Sriussadaporn S; Wong MS; Whitfield JF; Tembe V; Favus MJ
    Endocrinology; 1995 Sep; 136(9):3735-42. PubMed ID: 7649079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone and Nutrition. The vitamin D functions in osteoblasts and osteocytes].
    Sawatsubashi S
    Clin Calcium; 2015 Jul; 25(7):991-7. PubMed ID: 26119311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation.
    Oda Y; Sihlbom C; Chalkley RJ; Huang L; Rachez C; Chang CP; Burlingame AL; Freedman LP; Bikle DD
    Mol Endocrinol; 2003 Nov; 17(11):2329-39. PubMed ID: 12893881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.